跳至主要内容
临床试验/CTRI/2020/12/029712
CTRI/2020/12/029712尚未招募未知

Impact of glycemic variability on the outcome of patients diagnosed with SARS-COV 2 virus

Shravanthi Naidu S Woodayagiri0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients >18 years who have been diagnosed with SARS COV-2 infection by RTPCR analysis of the nasal swab specimen taken
  • Type2 diabetes and are on treatment
  • Patients with impaired glucose tolerance
  • FBS >100mg/dl but <126mg/dl
  • PPBS >140mg/dl but <200mg/dl
  • Stress induced hyperglycemia
  • Patients with no history of impaired glucose tolerance but have â??
  • Newly diagnosed diabetic patients (as per WHO guidelines)

排除标准

  • Patients <18 years of age with SARS COV-2 infection
  • Patients with chronic illness such as
  • Malignancies
  • Autoimmune disease
  • Chronic disease requiring steroids

研究者

发起方
Shravanthi Naidu S Woodayagiri

相似试验